Dr Zahraa Jalal

Dr Zahraa Jalal

School of Pharmacy
Associate Professor in Clinical Pharmacy and Therapeutics

Contact details

Address
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Zahraa is an Associate Professor in Clinical Pharmacy and Therapeutics; she has a sustained academic teaching background. She has taught both Undergraduate and Post Graduate Pharmacy Medical Students in subjects of Clinical Pharmacy and Clinical Pharmacology. Zahraa has contributed to the development of teaching programmes and materials. She has experience in primary and secondary healthcare research. Zahraa’s research interests include primary and secondary prevention of cardiovascular diseases and pharmacy service developments.

Other research interests include pharmaceutical care, communication skills for pharmacists and adherence to medicines. 

Qualifications

  • PhD in Clinical Pharmacy UCL School of Pharmacy 2016
  • Fellow of the Higher Education Academy 2014
  • MSc. Clinical Pharmacy University of London School of Pharmacy 2009
  • Postgraduate Certificate Clinical Pharmacy 1997
  • BSc. Pharmacy 1996

Biography

Zahraa graduated from Pharmacy School with a BSc. Pharmacy in 1996.  She enrolled in a one year Clinical Pharmacy training course in 1997. She worked as a Clinical Pharmacist in hospitals overseas.

Zahraa was Lead Clinical Pharmacist in three of the hospitals that she worked in and she became a Specialist Cardiac Pharmacist in 2003. After been granted a Chevening Scholarship (UK Government’s International Awards Scheme aimed at developing global leaders) to study for a Masters Degree. She enrolled onto the Clinical Pharmacy International Practice and Policy course at University of London School of Pharmacy, where she finished her MSc. in Clinical Pharmacy in 2009 with Distinction; during this course she had the opportunity to develop her research skills at The Harley Street Clinic in London.

In 2010, Zahraa taught Clinical Pharmacology to Medical Students and also worked to develop and implement a collaboration project (secured funding from UK Department for International Development) between Higher Education Institutions. This programme led to the development of a Clinical Pharmacy Diploma in a developing country.

In 2012, Zahraa commenced her PhD in Clinical Pharmacy at UCL School of Pharmacy and graduated in 2016. During her PhD she designed and executed a pilot randomised trial of a novel intervention in community pharmacy (collaborative work UCL School of Pharmacy, The London Chest Hospital and North East London Local Pharmaceutical Committee).

During her time at UCL, Zahraa taught on the MPharm programme and delivered lectures on Cardiovascular Medicine, she helped support the MSc.CPIPP in OSCEs and PBLs. She designed and delivered workshops on primary prevention of cardiovascular diseases to London Postgraduate Pharmacists as CPD courses. Zahraa also worked at UCL Research Department of Practice and Policy as a Researcher from 2011-2016.  

In 2016, Zahraa joined the team at College of Medical and Dental Sciences as a Lecturer in Clinical Pharmacy. 

Teaching

  • Clinical Pharmacy and Therapeutics
  • Cardiovascular Medicines
  • Post Graduate Pharmacy teaching 

Postgraduate supervision

Zahraa is interested in supervising research projects in the following areas:

- Clinical Pharmacy
- Pharmacy Services Development
- Pharmaceutical Care (Chronic Diseases)
- Pharmacy Consultations
- Adherence to Cardiovascular Medicines

Research

Zahraa’s main research interests include:

  • Safe and effective use of medicines and reducing medicines waste, adherence to medicines and medicine optimisation
  • Prescribing and patient safety
  • Pharmacy care and pharmacy services
  • Cardiovascular diseases
  • The rational use of antibiotics

Other activities

  • Developed and helped design a course on Motivational Interviewing for Pharmacists (collaboration work between UCL-School of Pharmacy, University of Buckingham and the London Chest hospital) for UK postgraduate pharmacists 2015.
  • Zahraa was invited to speak as an Expert Speaker at several conferences in the UK (NELLPC -2014) and abroad on Cardiovascular Medicines (2010).
  • In collaboration with NELLPC workshops for development of SelfCare Pharmacy. 
  • Zahraa gained funding in 2010 from DelPHE-DIFD for development of higher education- £44,600.00 and in 2013 funds from Marjorie Moss funding- £8,000.00.
  • Reviewer for BMJ group journals.

Publications

Recent publications

Article

Monshi, M, Jalal, Z, Pontefract, S & Cox, A 2026, 'Developing Quality of Medication Error Reports (QoMER): A Consensus-Based Preliminary Framework Using a Modified Nominal Group Technique in the UK', BMJ Open, vol. 16, no. 9, e115872. https://doi.org/10.1136/bmjopen-2025-115872

Whorton, A, Osman, S, Johal, J, Baig, S, Jones, AM & Jalal, Z 2026, 'Prescribing Patterns and Adverse Effects of Semaglutide: A Real-World Comparative Evaluation', Healthcare, vol. 14, no. 1, 35. https://doi.org/10.3390/healthcare14010035

Almunef, M, Mason, J, Curtis, CE & Jalal, Z 2025, 'Exploring young people’s views on pharmaceutical care for long-term illnesses in primary care settings', Healthcare, vol. 13, no. 21, 2796. https://doi.org/10.3390/healthcare13212796

Singh, J, Osman, S, Baig, S, Murad, Y & Jalal, Z 2025, 'Knowledge, Attitudes and Behaviours Towards Alcohol Consumption and Cardiovascular Health Among Healthcare Students of South Asian Heritage in the UK: A Qualitative Study', Pharmacy, vol. 13, no. 5, 136. https://doi.org/10.3390/pharmacy13050136

Gul, IZ, Baig, S, Glover, M, Virdee, M, Osman, S, Jenkins, D & Jalal, Z 2025, 'Optimisation of lipid-lowering therapy post-Acute Coronary Syndromes: A multidisciplinary, cross-interface novel pharmacy care model within a local cardiac rehabilitation centre', Journal of Pharmaceutical Policy and Practice, vol. 18, no. 1, 2523934. https://doi.org/10.1080/20523211.2025.2523934

Abstract

Aljead, M, Alsabhan, J, Qashta, A, Jalal, Z & Jones, AM 2026, 'Metabolic and Endocrine ADRs of Atypical Antipsychotics in Paediatric ASD: A Middle East Systematic Review', Frontiers in Drugs Safety and Regulation.

Aljead, M, Almeziny, M, Alghamadi, EA, Jalal, Z & Jones, AM 2026, 'Pharmacovigilance Evaluation of Adverse Drug Reactions with Atypical Antipsychotics in Paediatric Autism: Evidence from Saudi Food and Drug Authority Database', Frontiers in Drugs Safety and Regulation.

Other contribution

Aljead, M, Jones, AM & Jalal, Z 2025, The Prevalence of Metabolic and Endocrine Adverse Drug Reactions (ADRs) Associated with Atypical Antipsychotics in Children and Adolescents with Autism Spectrum Disorder (ASD) in Saudi Arabia: Systematic Review. PROSPERO. <https://www.crd.york.ac.uk/PROSPERO/view/CRD420251077872>

Poster

Whorton, A, Osman, S, Baig, S, Johal, J, Jones, AM & Jalal, Z 2025, 'Prescribing Patterns and Adverse Drug Reactions associated with Semaglutide: A real-world evaluation from a socioeconomically deprived UK region', Great North Pharmacy Research Collaborative Conference 2025, Gateshead, United Kingdom, 18/07/25 - 18/07/25.

Whorton, A, Osman, S, Baig, S, Johal, J, Jones, AM & Jalal, Z 2025, 'Prescribing Patterns and Adverse Effects of Semaglutide: A real-world evaluation from a socioeconomically deprived UK region', Autumn Symposium of the European Society of Clinical Pharmacy in Grenoble, Grenoble, France, 26/11/25 - 28/11/25.

Review article

Monshi, MM, Jalal, Z, Aston, J, Pontefract, SK & Cox, AR 2026, 'Educational Interventions Affecting Medication Error Reporting by Healthcare Professionals in Secondary and Tertiary Care: A Systematic Review and Narrative Synthesis', Drug Safety, vol. 49, no. 8, pp. 921-939. https://doi.org/10.1007/s40264-026-01668-4

Aljead, M, Qashta, A, Jalal, Z & Jones, AM 2025, 'Metabolic and Endocrine ADRs of Atypical Antipsychotics (AAPs) in Paediatric Patients with Autism Spectrum Disorder (ASD): A Review of Prevalence, Risk Factors, and Implications for Clinical Monitoring', Journal of Clinical Medicine, vol. 14, no. 22, 7942. https://doi.org/10.3390/jcm14227942

Celik Esmer, A, Jalal, Z, Guo, P & Seckin, M 2025, 'Prevalence and associated factors of eating disorders in adults with type 2 diabetes: a systematic review', Journal of Eating Disorders, vol. 13, 211. https://doi.org/10.1186/s40337-025-01391-y

Aljead, M, Qashta, A, Jalal, Z & Jones, AM 2025, 'Review of Autism spectrum disorder (ASD): Epidemiology, aetiology, pathology, and pharmacological treatment', Pharmaceuticals (Basel, Switzerland), vol. 18, no. 11, 1644. https://doi.org/10.3390/ph18111644

Osman, S, Hirsch, C, Jalal, Z & Paudyal, V 2025, 'Self-care education in primary schools and related settings in England: An ethnographic study', Health Education Journal, vol. 84, no. 1, pp. 82-94. https://doi.org/10.1177/00178969241309740

View all publications in research portal